Aligos Therapeutics (NASDAQ:ALGS – Get Free Report) posted its quarterly earnings data on Thursday. Aligos Therapeutics had a negative net margin of 1,919.68% and a negative return on equity of 139.47%. Aligos Therapeutics Stock PerformanceShares of ALGS stock traded up $0.77 during mid-day trading on Thursday, hitting $5.51. Aligos Therapeutics has a 52-week low of $3.98 and a 52-week high of $13.69. Read MoreReceive News & Ratings for Aligos Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aligos Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.